Serum NfL (sNfL), as a marker of neuronal cytoskeleton, has shown to increase in the cerebrospinal fluid (CSF) of several neurodegenerative disorders as well as autoimmune inflammatory diseases, including multiple sclerosis, SLE, and primary Sjøgren’s syndrome (17, 53). This evidence concerns the gene NEFL and multiple sclerosis.